LL2-11 digest — Ch11 DDT: fifty years since Silent Spring#

Late lessons II (EEA 2013), pp. 240–260 (PDF 242–262). By Bouwman, Bornman, van den Berg and Kylin. All four do DDT, malaria and persistent-pollutant research, or advise on it, in South Africa, the Netherlands and Sweden. About 17 of the chapter’s 112 references are their own work. Bornman also advised the WHO DDT hazard consultation whose assessment the chapter quotes. There are no panels.

Core story. This is a 50th-anniversary tribute to Silent Spring, about a case that is still open in 2013.

• DDT was synthesised in 1873 with no use in mind. Its insecticidal action was found in 1939. It controlled typhus in Naples in 1943–44 and became the backbone of global malaria eradication in the 1950s–60s (pp. 241, 243).
• The 1948 Nobel speech noted fly resistance but saw it as a prompt for new chemicals. It counted persistence, now DDT’s defining hazard, as a benefit (p. 241). Resistance (1948–51) was “one of the reasons” the eradication programme was abandoned in 1969 (p. 243).
• In Sweden, bird deaths and failing eagle reproduction appeared in the mid-1950s, and the figure’s “cause of damage emerges” phase starts around 1960. Most uses were banned around 1970. The DDT–eagle link was “confirmed” around 1980, after the bans, and the eagles then recovered (Fig. 11.1, p. 242).
• In 2013, DDT is still sprayed indoors (indoor residual spraying, IRS) under a Stockholm Convention exemption with no end date. Use is over 5,000 t a year and “has not declined substantially” since 2004. India is the sole producer and accounts for 82% of use. The number of African countries using it rose from 4 to 9 between 2000 and 2008; African tonnage then fell in 2009 (pp. 243–244).

Key evidence. - South Africa, 1996–2000. South Africa stopped using DDT. Pyrethroid-resistant An. funestus reinvaded, outbreaks followed, DDT was reintroduced, and cases declined (p. 243). Pyrethroids are still used “where viable” (Table 11.1, p. 253). The authors say this “probably increased the threshold of expectation of proof” for alternatives (p. 250). - Health. The chapter reports several associations, some of them inconsistent: breast cancer after pre-pubertal exposure (5× in one study), semen quality, birth defects (+33% in sprayed villages), miscarriage and preterm birth, neurodevelopment and diabetes (pp. 245–248). Several of these rest on single studies or the authors’ own work, and the lactation, testicular and Type 1 diabetes findings are null or unclear. WHO (2011) found IRS exposures “generally below potential levels of concern”, though higher in some areas (p. 252). The authors call the evidence “mounting” (p. 248). - Exposure. IRS residents are arguably “the largest non-occupationally exposed community in the world” (p. 248). Isomer patterns point mainly to home-produced food and soil, though modelling also flags indoor air, and the chapter does not reconcile the two. People who stay at home are “a particular concern”, and first-born infants receive more via breast milk. There is no breast-milk residue limit (pp. 247–249). IRS practice has been “static since … the early 1940s” (p. 249). - Legacy. 213 US Superfund sites list DDT. Remediation at one named formulator site “seems not to have been as effective as anticipated”, and DDT is being re-released from melting glaciers (pp. 249–250). Illegal diversion happens where regulators lack capacity (pp. 243–244).

Authors’ lessons and recommendations. - “Invoke precaution” through a “centrist-DDT position”: cut use and exposure rather than ban. “Maintaining that DDT is safe ignores the cumulative indications of many studies” (p. 248). - Reduce household exposure to all IRS chemicals (p. 249), and do research in IRS settings (p. 247). - Adopt integrated vector management that combines methods (pp. 251–252). - A “roadmap” exists but there is “no timetable”, and the end of DDT is “some way off” (p. 252). - The close asserts that we “missed the obvious early signposts” across environmental problems (p. 253).

Mechanisms. Most are covered in the insights below. Two that aren’t: - Visibility bias: birds are widely watched, while seals were seen only by fishermen who viewed them as pests (pp. 242–243). - Latency and critical exposure windows delay detection (pp. 245–247).

Transferable insights. 1. A technology’s most attractive feature can be its main hazard (pp. 241, 243). Strong. 2. Early signs of a technology’s limits get read as prompts to build “better versions” (pp. 241, 243). Strong for the 1948 reframing. Moderate for its link to the 1969 failure, since resistance was “one of the reasons” and the chapter doesn’t draw the link. 3. Adaptive targets wear down single-mode fixes unless the underlying pressure falls (pp. 243, 251). Strong. 4. Withdrawing an incumbent before a substitute is proven can backfire and raise the bar for substitutes (pp. 243, 250). Moderate. The authors themselves call the South African case “unique”. 5. Substitutes carry their own uncertainties (p. 250). Moderate as a principle; thinly evidenced here (two citations, one the authors’ own). 6. Whether harms are noticed depends on the tools available and on whether observers value what is harmed (pp. 242–243). Moderate. 7. Public attention redirects research, which then finds further hazards (p. 242). Moderate. 8. Acting before formal causal confirmation, on a decade of emerging evidence, was vindicated in Sweden (Fig. 11.1). Suggestive. This is my reading of the figure; the chapter doesn’t make the argument. 9. Restrictions to an “acceptable purpose” leak where enforcement is weak (pp. 243–244). Moderate. 10. Open-ended exemptions coexist with stable use (pp. 244, 252). Moderate. 11. When the protected and the exposed are the same people, the trade-off is made for them, and its burden falls unevenly (pp. 246–249). Moderate. The “made for them” part is my inference; the chapter doesn’t discuss consent. 12. Evidence is thinnest where exposure is highest (pp. 247–248). Moderate. 13. Cheap incumbents combined with slow-to-develop alternatives produce lock-in (pp. 243–244, 251–252). Moderate. 14. Persistent technologies leave costs that outlive their producers (pp. 249–250). Moderate. 15. Precaution can mean minimising exposure rather than prohibiting (pp. 248–252). Asserted, but reasoned.

Caveats. - The commemorative framing leads to unreferenced claims about Carson’s impact: the “return of the bird chorus”, and the idea that Kennedy led to a “complete ban” (p. 241). - The closing “missed signposts” section is rhetoric (p. 253). - Critics (The Lancet 2000; Tren and Roberts 2011) are cited but never summarised. - Malaria benefit is never weighed against health harm in numbers. - The South African recovery is attributed to DDT alone (p. 250), even though the chapter lists prompt treatment as a pillar of WHO malaria control (p. 252). I believe there were concurrent treatment changes; verify. - Several internal tensions go unreconciled: resistance “widespread” versus “absent”; illegal use “clear” versus “assumed” declining; air versus food as the main route (pp. 243–250). - The chapter leans heavily on the authors’ own work and over-reads one study (Cohn 2007). - Industry conduct is almost entirely absent. - There are citation errors. - To its credit, it credits DDT’s benefits and reports WHO’s more reassuring view. - For the hindsight check: the chapter gives IARC’s rating as “possibly carcinogenic” (p. 245). I believe IARC moved it to 2A in 2015; verify.